Previous
Previous
When simpler isn’t better: a case for generalized cost-effectiveness analysis
Next
Next
How should we think about the future? Are benefits to future populations worth the same as those for today’s patients? Economist Josh Cohen’s new paper rethinks and challenges conventional assumptions about the value of future treatments.